Different pharmacological approaches to increase SIRT3 expression or to enhance SIRT3 activity were a potent strategy to attenuate myocardial hypertrophy and other cardiovascular diseases [34–38]. This evidence concerns the gene SIRT3 and cardiac hypertrophy.